C

Cannabis Poland SA
WSE:CBD

Watchlist Manager
Cannabis Poland SA
WSE:CBD
Watchlist
Price: 0.1976 PLN 1.44% Market Closed
Market Cap: 14.7m PLN

Net Margin
Cannabis Poland SA

-4 113.6%
Current
-1 270%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-4 113.6%
=
Net Income
-2.2m
/
Revenue
52.9k

Net Margin Across Competitors

Country Company Market Cap Net
Margin
PL
Cannabis Poland SA
WSE:CBD
14.7m PLN
-4 114%
US
Eli Lilly and Co
NYSE:LLY
1T USD
31%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
US
Johnson & Johnson
NYSE:JNJ
498.9B USD
27%
CH
Roche Holding AG
SIX:ROG
261.4B CHF
15%
UK
AstraZeneca PLC
LSE:AZN
210.8B GBP
16%
CH
Novartis AG
SIX:NOVN
210.3B CHF
26%
US
Merck & Co Inc
NYSE:MRK
264.8B USD
30%
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK
33%
IE
Endo International PLC
LSE:0Y5F
213.9B USD
-126%
US
Pfizer Inc
NYSE:PFE
143.2B USD
16%
No Stocks Found

Cannabis Poland SA
Glance View

Market Cap
14.7m PLN
Industry
Pharmaceuticals

Cannabis Poland SA engages in the production and distribution of cannabinoid vaporization equipment and oils. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2013-04-09. The firm focuses on operating in the field of production and sale of pharmaceutical and medical products, with the main focus on vaporization products containing cannabinoids manufactured from cannabis. The firm also expands its activity to include other products than pharmaceuticals, such as cosmetics, oils containing cannabinoids for human and animals and photovoltaic cells. The firm is engaged in research and development of a Cannabidiol (CBD)/ Tetrahydrocannabinol-based (THC-based) pharmaceutical for use in the treatment of seizures associated with drug-resistant epilepsy.

CBD Intrinsic Value
0.0025 PLN
Overvaluation 99%
Intrinsic Value
Price
C
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-4 113.6%
=
Net Income
-2.2m
/
Revenue
52.9k
What is the Net Margin of Cannabis Poland SA?

Based on Cannabis Poland SA's most recent financial statements, the company has Net Margin of -4 113.6%.

Back to Top